Literature DB >> 33298302

Perceived need for drug treatment among African American male drug-using prisoners.

Jardin Dogan1, Danelle Stevens-Watkins2, Joi-Sheree Knighton3, Paris Wheeler4, Candice Hargons5.   

Abstract

Since 2016, African Americans have experienced the largest increase in cocaine-related drug overdose deaths compared to other racial/ethnic groups. African American male prisoners who used drugs prior to incarceration are at an increased risk for relapse and overdose upon community re-entry. Using the Theory of Planned Behavior as a guiding framework, this study examined correlates of perceived need for treatment among 193 drug-using incarcerated African American men nearing release. Linear regression analyses revealed that the number of lifetime drug overdoses, severity of legal problems, and previous drug treatment significantly predicted a need for treatment. Further, more frequent drug use, specifically crack cocaine, in the month prior to incarceration predicted a higher perceived need for drug treatment. Implications suggest this population demonstrates a need for treatment, which may be exacerbated by re-entry stressors. Preventative measures, including culturally tailored treatment and transitional care from prison to community-based services, are necessary to reduce risk of relapse and overdose among this group.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African Americans; Community Re-entry; Drug treatment; Male prisoners; Theory of Planned Behavior

Year:  2020        PMID: 33298302      PMCID: PMC7733029          DOI: 10.1016/j.jsat.2020.108166

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  61 in total

1.  Stigma, discrimination and the health of illicit drug users.

Authors:  Jennifer Ahern; Jennifer Stuber; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2006-11-21       Impact factor: 4.492

2.  The role of perceived need within the theory of planned behaviour: a comparison of exercise and healthy eating.

Authors:  Nicola Payne; Fiona Jones; Peter R Harris
Journal:  Br J Health Psychol       Date:  2004-11

3.  Predicting substance-abuse treatment providers' communication with clients about medication assisted treatment: a test of the theories of reasoned action and planned behavior.

Authors:  Anthony J Roberto; Michael S Shafer; Jennifer Marmo
Journal:  J Subst Abuse Treat       Date:  2014-06-18

4.  Drug Overdose Deaths Involving Fentanyl, 2011-2016.

Authors:  Merianne R Spencer; Margaret Warner; Brigham A Bastian; James P Trinidad; Holly Hedegaard
Journal:  Natl Vital Stat Rep       Date:  2019-03

5.  THE EFFECT OF STIGMA ON CRIMINAL OFFENDERS' FUNCTIONING: A LONGITUDINAL MEDIATIONAL MODEL.

Authors:  Kelly E Moore; Jeffrey B Stuewig; June P Tangney
Journal:  Deviant Behav       Date:  2015-12-23

Review 6.  Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Authors:  James J Mahoney
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-17       Impact factor: 3.157

7.  Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention.

Authors:  Michelle L Nolan; Sindhu Shamasunder; Cody Colon-Berezin; Hillary V Kunins; Denise Paone
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

8.  Powder cocaine and crack use in the United States: an examination of risk for arrest and socioeconomic disparities in use.

Authors:  Joseph J Palamar; Shelby Davies; Danielle C Ompad; Charles M Cleland; Michael Weitzman
Journal:  Drug Alcohol Depend       Date:  2015-02-02       Impact factor: 4.492

9.  Comparing Black and White Drug Offenders: Implications for Racial Disparities in Criminal Justice and Reentry Policy and Programming.

Authors:  Alana Rosenberg; Allison K Groves; Kim M Blankenship
Journal:  J Drug Issues       Date:  2016-12-21

10.  Risk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuse.

Authors:  Anders Håkansson; Mats Berglund
Journal:  BMC Psychiatry       Date:  2012-08-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.